Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:13.
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabetic Med. 2018;35(6):760–9.
Article CAS PubMed Google Scholar
Liu XB, Li YX, Guan L, He X, Zhang HL, Zhang J, et al. A systematic review and meta-analysis of the prevalence and risk factors of depression in type 2 diabetes patients in China. Front Med. 2022;9:16.
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control - A meta-analytic review of the literature. Diabetes Care. 2000;23(7):934–42.
Article CAS PubMed Google Scholar
Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med. 2003;65(3):376–83.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom Med. 2001;63(4):619–30.
Sieu N, Katon W, Lin EHB, Russo J, Ludman E, Ciechanowski P. Depression and incident diabetic retinopathy: a prospective cohort study. Gen Hosp Psych. 2011;33(5):429–35.
Wang Y, Yang H, Nolan M, Burgess J, Negishi K, Marwick TH. Association of depression with evolution of heart failure in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):19.
Katon WJ, Rutter C, Simon G, Lin EHB, Ludman E, Ciecranowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668–72.
Zhang XP, Norris SL, Gregg EW, Cheng YLJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005;161(7):652–60.
Darwish L, Beroncal E, Sison MV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. Diabetes Metab Syndr Obes. 2018;11:333–43.
Article PubMed PubMed Central Google Scholar
Guadalupe AZ, Gina DO, Alejandra TSP. Symptoms of anxiety and depression in type 2 diabetes: Associations with clinical diabetes measures and self-management outcomes in the norwegian HUNT study. Psychoneuroendocrinology. 2018;89:256-.
Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes. Diabetes Care. 2007;30(9):2222–7.
Lin EHB, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–60.
Sympa P, Vlachou E, Kazakos K, Govina O, Stamatiou G, Lavdaniti M. Depression and Self-Efficacy in Patients with Type 2 Diabetes in Northern Greece. Endocr Metab Immune Disord Drug Targets. 2018;18(4):371–8.
Article CAS PubMed Google Scholar
Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, et al. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Health Technol Assess. 2020;24(28):1–232.
Article PubMed PubMed Central Google Scholar
Rose M, Fliege H, Hildebrandt M, Schirop T, Klapp BF. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care. 2002;25(1):35–42.
Yi JP, Vitaliano PP, Smith RE, Yi JC, Weinger K. The role of resilience on psychological adjustment and physical health in patients with diabetes. Br J Health Psychol. 2008;13:311–25.
Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications. 2012;26(1):10–6.
Topp CW, Ostergaard SD, Sondergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):10.
Carrozzino D, Christensen KS, Cosci F. Construct and criterion validity of patient-reported outcomes (PROs) for depression: a clinimetric comparison. J Affect Disord. 2021;283:30–5.
Lindert J, Bain PA, Kubzansky LD, Stein C. Well-being measurement and the WHO health policy Health 2010: systematic review of measurement scales. Eur J Public Health. 2015;25(4):731–40.
Fung SF, Kong CYW, Liu YM, Huang Q, Xiong ZK, Jiang ZQ, et al. Validity and psychometric evaluation of the Chinese version of the 5-Item WHO Well-Being Index. Front Public Health. 2022;10:8.
Chang AM, Chau JPC, Holroyd E. Translation of questionnaires and issues of equivalence. J Adv Nurs. 1999;29(2):316–22.
Article CAS PubMed Google Scholar
Sheehan DV, Janavs J, Baker R, Harnett-Sheehan K, Knapp E, Sheehan M, et al. MINI - Mini International Neuropsychiatric Interview - English Version 5.0.0 - DSM-IV. J Clin Psychiatry. 1998;59:34–57.
Zheng YP, Zhao JP, Phillips M, Liu JB, Cai MF, Sun SQ, et al. Validity and reliability of the Chinese Hamilton depression rating-scale. Br J Psychiatry. 1988;152:660–4.
Article CAS PubMed Google Scholar
Huang MF, Courtney M, Edwards H, McDowell J. Validation of the Chinese version of the Problem Areas in Diabetes (PAID-C) scale. Diabetes Care. 2010;33(1):38–40.
Yin LA, Teklu S, Pham H, Li RCY, Tahir P, Garcia ME. Validity of the Chinese language patient health questionnaire 2 and 9: a systematic review. Health Equity. 2022;6(1):574–94.
Article PubMed PubMed Central Google Scholar
Suhaimi AF, Makki SM, Tan KA, Silim UA, Ibrahim N. Translation and validation of the malay version of the who-5 well-being index: reliability and validity evidence from a sample of Type 2 diabetes mellitus patients. Int J Environ Res Public Health. 2022;19(7):11.
Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107(2):238–46.
Article CAS PubMed Google Scholar
Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor-analysis. Psychometrika. 1973;38(1):1–10.
DiStefano C. The impact of categorization with confirmatory factor analysis. Struct Equation Model. 2002;9(3):327–46.
Saipanish R, Lotrakul M, Sumrithe S. Reliability and validity of the Thai version of the WHO-Five Well-Being Index in primary care patients. Psychiatry Clin Neurosci. 2009;63(2):141–6.
Awata S, Bech P, Yoshida S, Hirai M, Suzuki S, Yamashita M, et al. Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients. Psychiatry Clin Neurosci. 2007;61(1):112–9.
Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord. 2004;78(2):131–40.
Liu L, Li SP, Zhao Y, Zhang JL, Chen G. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China. Qual Life Res. 2018;27(5):1323–33.
Gao JL, Zheng PP, Jia YN, Chen H, Mao YM, Chen SH, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS One. 2020;15(4):10.
Ahmed HAS, Mohamed SF, Mostafa M, Elotla SF, Shah A, Shah J, et al. Psychometric evaluation of the Arabic version of the 5-item Problem Areas in Diabetes (AR-PAID-5) scale. BMC Primary Care. 2022;23(1):148.
Cichon E, Kiejna A, Gondek TM, Obrebski M, Sutkowska E, Lloyd CE, et al. PAID-PL-The Polish Version of the Problem Areas in Diabetes Scale: Perfect Reliability and a One-Factor Structure. Diabetes Metab Syndr Obes. 2021;14:4433-41
Cichon E, Kiejna A, Kokoszka A, Gondek T, Rajba B, Lloyd CE, et al. Validation of the Polish version of WHO-5 as a screening instrument for depression in adults with diabetes. Diabetes Res Clin Pract. 2020;159:107970.
Hajos TRS, Pouwer F, Skovlund SE, Den Oudsten BL, Geelhoed-Duijvestijn P, Tack CJ, et al. Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus. Diabetic Med. 2013;30(2):E63-E9
Huis In 't Veld EMJ, Makine C, Nouwen A, Karsidag C, Kadioglu P, Karsidag K, et al. Validation of the Turkish version of the problem areas in diabetes scale. Cardiovasc Psychiatry Neurology. 2011;2011:315068-.
Papanas N, Tsapas A, Papatheodorou K, Papazoglou D, Bekiari E, Sariganni M, et al. Glycaemic control is correlated with well-being index (WHO-5) in subjects with Type 2 diabetes. Exp Clin Endocrinol Diabetes. 2010;118(6):364–7.
Article CAS PubMed Google Scholar
Prinz N, Ebner S, Grunerbel A, Henkeludecke U, Hermanns N, Hummel M, et al. Female sex, young age, northern German residence, hypoglycemia and disabling diabetes complications are associated with depressed mood in the WHO-5 questionnaire - a multicenter DPV study among 17,563 adult patients with type 2 diabetes. J Affect Disord. 2017;208:384–91.
Łukasiewicz A, Cichoń E, Kostecka B, Kiejna A, Jodko-Modlińska A, Obrębski M, et al. Association of higher rates of Type 2 Diabetes (T2DM) complications with psychological and demographic variables: results of a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:3303–17.
Article PubMed PubMed Central Google Scholar
Halliday JA, Hendrieckx C, Busija L, Browne JL, Nefs G, Pouwer F, et al. Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: results from diabetes MILES - Australia. Diabetes Res Clin Pract. 2017;132:27–35.
Comments (0)